# Observation on the Effect of Sacubitril/Valsartan in Advanced Chronic Kidney Disease（CKD）Patients With Heart Failure

> **NCT03771729** · EARLY_PHASE1 · UNKNOWN · sponsor: **The Second Affiliated Hospital of Harbin Medical University** · enrollment: 30 (estimated)

## Conditions studied

- CKD

## Interventions

- **DRUG:** LCZ 696

## Key facts

- **NCT ID:** NCT03771729
- **Lead sponsor:** The Second Affiliated Hospital of Harbin Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-30
- **Primary completion:** 2019-05-28
- **Final completion:** 2019-06-15
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03771729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03771729, "Observation on the Effect of Sacubitril/Valsartan in Advanced Chronic Kidney Disease（CKD）Patients With Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03771729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*